Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $3.64 Million - $4.56 Million
98,000 New
98,000 $3.7 Million
Q1 2019

May 14, 2019

SELL
$52.92 - $81.17 $3.5 Million - $5.37 Million
-66,200 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $1.52 Million - $2.08 Million
35,000 Added 112.18%
66,200 $3.58 Million
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $1.34 Million - $1.68 Million
31,200 New
31,200 $1.61 Million
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $940,296 - $1.18 Million
-23,200 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$44.08 - $55.05 $1.02 Million - $1.28 Million
23,200 New
23,200 $1.02 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.